All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Sunovion Pharmaceuticals Inc., of Marlborough, Mass., reported results from the first placebo-controlled study of dasotraline for the treatment of adult patients with attention deficit hyperactivity disorder (ADHD) at the American College of Neuropsychopharmacology meeting in Phoenix.